Clinical Trials
4
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Colonic Transit Time Validation Study
- Conditions
- Constipation
- First Posted Date
- 2009-03-06
- Last Posted Date
- 2010-01-15
- Lead Sponsor
- The SmartPill Corporation
- Target Recruit Count
- 210
- Registration Number
- NCT00857363
- Locations
- 🇺🇸
University of Arizona Health and Sciences Ctr Southern Arizona VA HealthCare System, Tucson, Arizona, United States
🇺🇸Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸University of Iowa, Iowa City, Iowa, United States
A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time - Over 65 Years Old
- Conditions
- Gastrointestinal DiseasesStomach DiseasesGastroparesis
- First Posted Date
- 2008-05-23
- Last Posted Date
- 2008-05-23
- Lead Sponsor
- The SmartPill Corporation
- Target Recruit Count
- 23
- Registration Number
- NCT00682877
- Locations
- 🇺🇸
Division of Gastroenterology and Hepatology at KUMC, Kansas City, Kansas, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
Assessment of Whole Gut Transit Time Using the SmartPill Capsule
- Conditions
- Constipation
- First Posted Date
- 2008-01-29
- Last Posted Date
- 2008-08-29
- Lead Sponsor
- The SmartPill Corporation
- Target Recruit Count
- 178
- Registration Number
- NCT00603707
- Locations
- 🇺🇸
Mayo Clinic, Scottsdale, Scottsdale, Arizona, United States
🇺🇸University of Iowa, Iowa City, Iowa, United States
🇺🇸Kansas University Medical Center, Kansas City, Kansas, United States
A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time
- Conditions
- Gastrointestinal DiseasesStomach DiseasesGastroparesis
- First Posted Date
- 2005-08-09
- Last Posted Date
- 2008-05-22
- Lead Sponsor
- The SmartPill Corporation
- Target Recruit Count
- 148
- Registration Number
- NCT00128284
- Locations
- 🇺🇸
Division of Gastroenterology and Hepatology at KUMC, Kansas City, Kansas, United States
🇺🇸University of Louisville Medical Center, Louisville, Kentucky, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
News
AnX Robotica Receives FDA 510(k) Clearance for MotiliCap and MotiliScan GI Motility Monitoring System
AnX Robotica announced FDA 510(k) clearance for MotiliCap and MotiliScan, a next-generation gastrointestinal motility monitoring system that replaces the discontinued SmartPill technology.